Videos

It's Not Your Fault. It's Genetic.
Diagnosing and Understanding Genetic Obesity
The Social Stigma of POMC
Why Seeking a Diagnosis is Important
Interested in The Genetic Obesity Project?
Stay informed about our latest developments and projects.
This program is supported by Rhythm, a Boston-based biopharmaceutical company developing the MC4R peptide agonist, setmelanotide (RM-493), for obesity caused by genetic deficiencies in the MC4 pathway.
Back to Top